Study Stopped
Trial discontinued due to unreliable wearable device.
Using Wearable Technology to Detect Symptoms of Posttraumatic Stress Disorder
1 other identifier
observational
14
1 country
1
Brief Summary
The aim of the project is to advance our understanding of how individuals with Posttraumatic Stress Disorder (PTSD) experience symptoms in their every-day lives when they are in their home environment. To date, all PTSD assessments are retrospective; individuals with PTSD are asked to recount and report their symptoms over the past weeks or months. Such assessment procedures are negatively impacted by individuals' abilities to accurately recall information. Moreover, retrospective assessments provide little information about how symptoms are experienced in the moment and how these experiences then lead to other behaviors. The proposed project addresses these limitations by assessing PTSD symptoms and associated biological markers (e.g., sleep, heart rate, heart rate variability) in real-time by asking subjects to wear a smart device and complete brief surveys. Data will be collected from 50 individuals with PTSD and 20 healthy controls to help us better understand individuals' real-time experience with PTSD and lay the foundation to develop algorithms for possible in-the-moment interventions in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 9, 2022
CompletedStudy Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedOctober 18, 2023
October 1, 2023
10 months
September 6, 2022
October 16, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Clinician Administered PTSD Scale for DSM-5
Clinician administered measure of PTSD
Through study completion, average of 1 month
PTSD Checklist for DSM-5 Criteria
Self-report measure of PTSD
Through study completion, average of 1 month
Study Arms (2)
Healthy Control
PTSD
Interventions
Participants in both groups will wear the Biostrap wearable device
Eligibility Criteria
Individuals who either present as a healthy control or are deemed to have PTSD by the CAPS
You may qualify if:
- Are 18 years or older
- Are fluent in English
- Have an active smart phone or smart device with full data and Bluetooth capability
- Have experienced a Criterion A traumatic event during their lifetime
- Have a PTSD diagnosis verified by the Clinician Administered PTSD Scale for DSM-5 and a symptom severity score of 35 or higher.
- Are willing and able to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
- Are willing to wear a smart device 24/7 over the course of one month.
You may not qualify if:
- The traumatic event occurred in the past month
- They are currently suicidal or homicidal
- They have a history of psychosis or mania
- They have a known, diagnosed heart condition
- They are currently receiving treatment for their PTSD or have completed an evidence- based PTSD treatment in the past 3 months
- They have a serious or unstable medical illness or instability for which hospitalization may be likely
- Subjects who, at the time of consent, appear to have extenuating life circumstances (unstable housing, no internet access, etc.) which, in the judgement of the Principal Investigator, could affect their ability to participate in the study
- Individuals are eligible for the current study if they:
- Are 18 years or older
- Are fluent in English
- Have an active smart phone or smart device with full data and Bluetooth capability
- Are willing and able to complete self-report measures and clinician-rated assessments at multiple time points over the course of the study
- Are willing to wear a smart device 24/7 over the course of one month.
- Individuals are excluded from the current study if they:
- Score a 10 or higher on the Clinician Administered PTSD Scale for DSM-5
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Director
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 9, 2022
Study Start
November 1, 2022
Primary Completion
September 1, 2023
Study Completion
September 1, 2023
Last Updated
October 18, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share